PROSTATE CANCER METASTATIC
Clinical trials for PROSTATE CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat prostate cancer
Disease control OngoingThis study is testing whether a combination of two drugs, pembrolizumab and lenvatinib, can help control an aggressive form of prostate cancer that has spread. It is for men whose cancer has developed neuroendocrine features and has stopped responding to standard hormone therapie…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Zapping spots: can targeted radiation boost prostate cancer treatment?
Disease control OngoingThis study is testing if adding targeted radiation or surgery to destroy a few cancer spots improves outcomes for men whose prostate cancer has spread. It compares standard hormone-blocking drugs alone to those drugs plus this 'ablative therapy' to all visible cancer sites. The g…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial offers hope for patients with advanced cancers out of options
Disease control OngoingThis early-stage study is testing a new drug called ST101 in patients with advanced solid tumors that cannot be surgically removed and have spread. The trial aims to find a safe and effective dose for cancers including glioblastoma, melanoma, breast cancer, and prostate cancer in…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Targeted radiation zaps advanced prostate cancer in new trial
Disease control ENROLLING_BY_INVITATIONThis study is testing a new, personalized radiation treatment for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking drugs. The treatment uses a radioactive drug that seeks out and delivers radiation directly to prostate can…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New scan could give clearer picture of prostate cancer
Diagnosis OngoingThis study is testing whether a new type of imaging scan, called a PSMA PET scan, is more accurate than standard scans at showing how prostate cancer responds to treatment. Researchers will follow 58 men with progressive prostate cancer. The goal is to see if changes on these spe…
Matched conditions: PROSTATE CANCER METASTATIC
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Prostate cancer drugs put to the test: which one protects your mind?
Symptom relief OngoingThis study aims to find out which of two common prostate cancer medications—enzalutamide or darolutamide—has less impact on memory, concentration, and other thinking skills. About 111 men with advanced prostate cancer will take one of the drugs and complete regular computer-based…
Matched conditions: PROSTATE CANCER METASTATIC
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC